Venrock has raised $400 million for its Venrock Healthcare Capital Partners III cross-over biotech fund, according to an SEC filing posted this week.
The total funds raised include a commitment from Venrock’s general partner, VHCP Management III, according to the SEC filing.
Venrock has not yet released any detailed plans on how it will spend money raised for the cross-over biotech fund.
The fund is being led by Bong Koh and Nimish Shah, according to the SEC filing.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!